DNA Aptamers for Rapid COVID-19 Testing: Interview with Steven Goh, CEO of Achiko and Dr. Michael Edel, Inventor of AptameX
Achiko, a company based in Switzerland, has developed AptameX, a saliva-based rapid COVID-19 test. The technology is based on DNA aptamers that are bound to gold nanoparticles. On binding with a viral protein the gold nanoparticles are released, caus...
Source: Medgadget - Category: Medical Devices Authors: Conn Hastings Tags: Exclusive Genetics Medicine Public Health Achiko AptameX covid Source Type: blogs
More News: Chemistry | COVID-19 | Emergency Medicine | Genetics | Indonesia Health | International Medicine & Public Health | Laboratory Medicine | Medical Devices | Nanotechnology | Pandemics | PET Scan | Switzerland Health | Vaccines